Published in Hepatitis Weekly, February 28th, 2005
"In the study presented here the ribavirin mutagenic effect was investigated by analyzing quasispecies in the viral 5' untranslated region of hepatitis C virus in six patients with chronic infection who started interferon-alpha and ribavirin therapy. A remarkable mutation rate during treatment was found in only one individual," according to scientists writing in the European Journal of Clinical Microbiology & Infectious Diseases.
"This patient had a sustained response and harbored a type 3a virus strain. The different mutated clones in this patient demonstrated no apparent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.